| # | Drug | Count |
|---|---|---|
| 0 | IRON SUCROSE | 149 |
| 1 | IOHEXOL | 133 |
| 2 | FLUOROURACIL | 123 |
| 3 | FLUOROURACIL CREAM, 0.5% | 123 |
| 4 | OXALIPLATIN | 113 |
| 5 | RITUXIMAB | 104 |
| 6 | CYCLOPHOSPHAMIDE | 101 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 101 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 101 |
| 9 | BENDAMUSTINE HYDROCHLORIDE | 93 |
| # | Drug class | Count |
|---|---|---|
| 0 | Radiographic Contrast Agent [EPC] | 249 |
| 1 | Platinum-based Drug [EPC] | 238 |
| 2 | Corticosteroid [EPC] | 224 |
| 3 | Parenteral Iron Replacement [EPC] | 193 |
| 4 | Alkylating Drug [EPC] | 181 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 159 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 146 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 142 |
| 8 | Osmotic Laxative [EPC] | 93 |
| 9 | Microtubule Inhibitor [EPC] | 91 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Parenteral Iron Replacement [EPC] | 193 | 0.0140 |
| 1 | Radiographic Contrast Agent [EPC] | 249 | 0.0096 |
| 2 | Sclerosing Agent [EPC] | 4 | 0.0089 |
| 3 | Adenosine Receptor Agonist [EPC] | 50 | 0.0068 |
| 4 | Cholecystokinin Analog [EPC] | 1 | 0.0065 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 37 | 0.0063 |
| 6 | Lipid Emulsion [EPC] | 15 | 0.0057 |
| 7 | Lymphocyte Activation Gene-3 Blocker [EPC] | 2 | 0.0039 |
| 8 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 49 | 0.0037 |
| 9 | Interleukin-6 Antagonist [EPC] | 2 | 0.0031 |